Skip to content

Author

Milon de Jong

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access

Exploring the immunotherapeutic potential of Vγ9Vδ2-T cells in cancer using bispecific antibodies

Bispecific T cell engagers (bsTCEs) are engineered antibodies designed to simultaneously bind a tumor-associated antigen (TAA) and, most commonly, the CD3 complex on T cells. By bridging tumor and effector cells, bsTCEs promote the formation of an immunological synapse that triggers potent cytotoxic responses, bypassin...

Milon de Jong · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.